Coagulation Factor X antibody (Cleaved-Ile235)
Quick Overview for Coagulation Factor X antibody (Cleaved-Ile235) (ABIN486716)
Target
See all Coagulation Factor X (F10) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 216-265, Cleaved-Ile235
-
Purpose
- Cleaved-Factor Xa activated HC (I235) Antibody
-
Specificity
- Cleaved-Factor Xa activated HC (I235) Polyclonal Antibody detects endogenous levels of fragment of activated Factor Xa activated HC protein resulting from cleavage adjacent to I235.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Purity
- > 95 %
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human FA10. AA range:216-265
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500 - 1:2000. ELISA: 1:20000. Not yet tested in other applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C/1 year
-
Expiry Date
- 12 months
-
-
- Coagulation Factor X (F10)
-
Alternative Name
- FA10
-
Background
-
Synonyms: F10, Coagulation factor X, Stuart factor, Stuart-Prower factor
Background: This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds, the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative sp
Gene Name: F10
Protein Name: Coagulation factor X
-
Molecular Weight
- 30 kDa
-
Gene ID
- 2159
-
OMIM
- 227600
-
UniProt
- P00742
Target
-